Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,084.00    -28.00 (-0.90%)
Bid:
3,088.00
Ask:
3,091.00
Spread: 3.00 (0.097%)
Market Cap: £4.30b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Annual Financial Report

25 Mar 2021 10:55

RNS Number : 4960T
Croda International PLC
25 March 2021
 

Croda International Plc - Annual Financial Report and Notice of AGM

 

Croda International Plc (the "Company") announced its Annual Results for the year ended 31 December 2020 (the "Annual Results Announcement") on 2 March 2021. Further to the Annual Results announcement, the Company is pleased to confirm that the following documents have been published and mailed to shareholders:

 

- Annual Report and Accounts for the year ended 31 December 2020

- Notice of Annual General Meeting (the "Notice")

- Sustainability Report.

 

Shareholders who have elected not to receive hard copy documents will receive a letter from the Company advising that the above listed documents are now available.

 

The Annual General Meeting of the Company will be held at 12 noon on 21 May 2021 at Cowick Hall, Snaith, Goole, East Yorkshire, DN14 9AA. The Board is closely monitoring the evolving Covid-19 (Coronavirus) situation and will continue to have regard for the developments and to act in accordance with the guidance issued by the UK Government and relevant health authorities over the coming weeks ahead of the AGM. Currently, legislation and government guidance relating to COVID-19 prohibits public gatherings and restricts non-essential travel. Given the constantly evolving nature of the situation, there can be no guarantee that the current restrictions will not still be in force on the date of the AGM. The health and safety of our shareholders and colleagues is also our priority in making the arrangements for the AGM. As a result, and given the current restrictions, shareholders are strongly advised not to attend the AGM.

 

Details of how shareholders appoint a proxy are detailed in the Notice and shareholders are requested to appoint a proxy as early as possible to ensure their votes are counted. Shareholders are requested to monitor the Company's website and announcements for any updates in relation to the AGM.

 

Although the Company does not expect to have the opportunity to meet with its shareholders in person at the AGM this year, the Board is very keen to engage with all shareholders and will therefore be holding an online pre-AGM shareholder event at 2.30pm on 13 May 2021. More details of this event, and other ways in which shareholders can engage with the Company, are set out in the Notice.

 

In compliance with DTR 6.3.5(3) the Annual Report and Accounts for the year ended 31 December 2020 and the Notice of Annual General Meeting are available on the Company's website on both the home page (www.croda.com) and the Annual Report page (www.croda.com/investors/annual-report).

 

In accordance with Listing Rule 9.6.1 a copy of each of these documents has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

For further information, please contact:

 

 

 

 

Tom Brophy

Group General Counsel and Company Secretary

+44 (0)1405 860551

 

25 March 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSDKPBNKBKDANB
Date   Source Headline
11th Jun 20262:58 pmRNSDirector/PDMR Shareholding
11th Jun 20269:15 amRNSDirector Declaration
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.